News

Pharmabiz19h
EMA recommends marketing authorization to Cordex Biologics’ new stem cell therapy, Zemcelpro to treat patients with blood cancers
Amsterdam, The Netherlands Monday, June 23, 2025, 12:00 Hrs [IST] ...
GlobalData on MSN17h
EC approves argenx’s efgartigimod alfa for CIDP treatment
The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.